NCT03801395View on ClinicalTrials.gov

PCD New Gene Discovery

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

November 20, 2024

Conditions
Primary Ciliary Dyskinesia
Interventions
OTHER

There is no intervention

No intervention

Trial Locations (1)

37232

Vanderbilt Children's hospital, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03801395 - PCD New Gene Discovery | Biotech Hunter | Biotech Hunter